Local carotid atherosclerotic plaque proteins for the identification of circulating biomarkers in coronary patients

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 551-558

  Malaud, Eric ^a   Merle, Delphine ^a   Piquer, Dominique ^a   Molina, Laurence ^a   Salvetat, Nicolas ^a   Rubrecht, Laetitia ^a   Dupaty, Emilie ^a   Galea, Pascale ^a   Cobo, Sandra ^a   Blanc, Aurélie ^a   Saussine, Max ^b   Marty Ané, Charles ^b   Albat, Bernard ^b   Meilhac, Olivier ^c   Rieunier, Francois ^d   Pouzet, Agnes ^d   Molina, Franck ^a   Laune, Daniel ^a   Fareh, Jeannette ^a  

^a UMR3145 CNRS Bio Rad   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c BICHAT HOSPITAL   (France)

^d Bio Rad   (France)

Author keywords

Atherosclerosis; Biomarkers; Prediction; Proteomic; Vulnerable plaque

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BIOLOGICAL MARKER; CALPONIN; CALPONIN 1; DJ 1 PROTEIN; GAMMA AMINOBUTYRIC ACID RECEPTOR ASSOCIATED PROTEIN LIKE 1; GAMMA AMINOBUTYRIC ACID RECEPTOR ASSOCIATED PROTEIN LIKE 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MICROTUBULE ASSOCIATED PROTEIN 1; PROTEIN 14 3 3; RANTES; UNCLASSIFIED DRUG; VASCULOTROPIN; CHEMOKINE; CYTOKINE; LIGAND; PEPTIDE LIBRARY; PLASMA PROTEIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTOPHAGY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COMPUTER MODEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEGRANULATION; FIBRINOLYSIS; FIBROTIC PLAQUE; HEMORRHAGIC ATHEROSCLEROTIC PLAQUES; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLATELET DEGRANULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STABLE ANGINA PECTORIS; TWO DIMENSIONAL ELECTROPHORESIS; UNSTABLE ANGINA PECTORIS; VASCULAR AUTOPHAGY; VASCULAR FIBROSIS; VERY ELDERLY; BLOOD; CAROTID ARTERY DISEASES; CAROTID ENDARTERECTOMY; CHEMISTRY; COMBINATORIAL CHEMISTRY; COMPARATIVE STUDY; DISEASE PREDISPOSITION; FEMALE; FIBROSIS; HEMORRHAGE; IMAGE SUBTRACTION; INFLAMMATION; MALE; PEPTIDE LIBRARY; RUPTURE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PROTEINS; CAROTID ARTERY DISEASES; CHEMOKINES; COMBINATORIAL CHEMISTRY TECHNIQUES; CORONARY ARTERY DISEASE; CYTOKINES; DISEASE SUSCEPTIBILITY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDARTERECTOMY, CAROTID; FEMALE; FIBROSIS; HEMORRHAGE; HUMANS; INFLAMMATION; LIGANDS; MALE; MIDDLE AGED; PEPTIDE LIBRARY; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS; SUBTRACTION TECHNIQUE;

EID: 84896282023     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.019     Document Type: Article

References (41)

1. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
2. Calabrò P., Golia E., Yeh E.T. CRP and the risk of atherosclerotic events. Semin Immunopathol 2009, 31:79-94.
3. Wykrzykowska J.J., Garcia-Garcia H.M., Goedhart D., Zalewski A., Serruys P.W. Differential protein biomarker expression and their time-course in patients with a spectrum of stable and unstable coronary syndromes in the Integrated Biomarker and Imaging Study-1 (IBIS-1). Int J Cardiol 2011, 149:10-16.
4. Eitel I., Blase P., Adams V., et al. Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance. Heart 2011, 97:632-640.
5. Kaski J.C., Fernández-Bergés D.J., Consuegra-Sánchez L., et al. A comparative study of biomarkers for risk prediction in acute coronary syndrome-results of the SIESTA (systemic inflammation evaluation in non-ST-elevation acute coronary syndrome) study. Atherosclerosis 2010, 212:636-643.
6. Hellings W.E., Peeters W., Moll F.L., et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010, 121:1941-1950.
7. de Kleijn D.P., Moll F.L., Hellings W.E., et al. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010, 30:612-619.
8. van Lammeren G.W., Pasterkamp G., de Vries J.P., et al. Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: a histopathological study in carotid plaques. Atherosclerosis 2012, 222:355-359.
9. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005, 25:2054-2061.
10. Derksen W.J., Peeters W., van Lammeren G.W., et al. Different stages of intraplaque hemorrhage are associated with different plaque phenotypes: a large histopathological study in 794 carotid and 276 femoral endarterectomy specimens. Atherosclerosis 2011, 218:369-377.
11. Michel J.B., Virmani R., Arbustini E., Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011, 32:1977-1985.
12. Leclercq A., Houard X., Philippe M., et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 2007, 82:1420-1429.
13. Ionita M.G., Vink A., Dijke I.E., et al. High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol 2009, 29:1220-1227.
14. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
15. Sluijter J.P., Pulskens W.P., Schoneveld A.H., et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 2006, 37:235-239.
16. Reininger A.J., Bernlochner I., Penz S.M., et al. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol 2010, 55:1147-1158.
17. Lepedda A., et al. Overview of current proteomic approaches for discovery of vascular biomarkers of atherosclerosis, proteomics - human diseases and protein functions 2012, InTech, Available from. http://www.intechopen.com/books/proteomics-human-diseases-and-protein-functions/overview-of-current-proteomic-approaches-for-discovery-of-vascular-biomarkers-of-atherosclerosis, T.-K. Man, R.J. Flores (Eds.).
18. Lepedda A.J., Cigliano A., Cherchi G.M., et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2009, 203:112-118.
19. Durán M.C., Martín-Ventura J.L., Mohammed S., et al. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Eur J Pharmacol 2007, 562:119-129.
20. Olson F.J., Sihlbom C., Davidsson P., Hulthe J., Fagerberg B., Bergström G. Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques. Biochem Biophys Res Commun 2010, 401:574-580.
21. Righetti P.G., Fasoli E., Boschetti E. Combinatorial peptide ligand libraries: the conquest of the 'hidden proteome' advances at great strides. Electrophoresis 2001, 32:960-966.
22. Malaud E., Piquer D., Merle D., et al. Carotid atherosclerotic plaques: proteomics study after a low-abundance protein enrichment step. Electrophoresis 2012, 33:470-482.
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
24. Ranaldi S., Caillava C., Promé S., et al. N-truncated Aβ peptides in complex fluids unraveled by new specific immunoassays. Neurobiol Aging 2013, 34:523-539.
25. Park H.K., Park E.C., Bae S.W., et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006, 114:886-893.
26. Léger T., Lavigne D., Le Caër J.P., et al. Solid-phase hexapeptide ligand libraries open up new perspectives in the discovery of biomarkers in human plasma. Clin Chim Acta 2011, 412:740-747.
27. Gomez D., Owens G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012, 95:156-164.
28. Moiseeva E.P., Belkin A.M., Spurr N.K., Koteliansky V.E., Critchley D.R. A novel dystrophin/utrophin-associated protein is an enzymatically inactive member of the phosphoglucomutase superfamily. Eur J Biochem 1996, 235:103-113.
29. Mölleken C., Sitek B., Henkel C., et al. Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 2009, 49:1257-1266.
30. de la Cuesta F., Barderas M.G., Calvo E., et al. Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. J Proteomics 2012, 75:2960-2971.
31. Wilson M.A. The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal 2011, 15:111-122.
32. Luo C., Li Y., Wang H., et al. Mitochondrial accumulation under oxidative stress is due to defects in autophagy. J Cell Biochem 2013, 114:212-219.
33. Moreno J.A., Ortega-Gómez A., Delbosc S., et al. In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis. Eur Heart J 2012, 33:252-263.
34. Arrigo A.P. The cellular "networking" of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. Adv Exp Med Biol 2007, 594:14-26.
35. Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110:2216-2219.
36. Park J.G., Yoo J.Y., Jeong S.J., et al. Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. Circ Res 2011, 109:739-749.
37. Barascuk N., Skjøt-Arkil H., Register T.C., et al. Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes. BMC Cardiovasc Disord 2010, 10:19.
38. De Meyer G.R., Martinet W. Autophagy in the cardiovascular system. Biochem Biophys Acta 2009, 1793:1485-1495.
39. Liao X., Sluimer J.C., Wang Y., et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 2012, 15:545-553.
40. Romuk E., Skrzep-Poloczek B., Wojciechowska C., et al. Selectin-P and interleukin-8 plasma levels in coronary heart disease patients. Eur J Clin Invest 2002, 32:657-661.
41. Boekholdt S.M., Peters R.J., Hack C.E., et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004, 24:1503-1508.